Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria
April 8, 2024
April 8, 2024
Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell’s Supervisory Board
March 13, 2024
March 13, 2024
[Replay] Medincell Presentation at Evercore ISI 2024 Emerging Biotech Conference
February 28, 2024
February 28, 2024
MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK)
January 31, 2024
January 31, 2024
Teva announces recruitment completion of phase 3 clinical study of mdc-TJK
January 9, 2024
January 9, 2024
Jefferies initiates MedinCell’s coverage with a “Buy” recommendation
January 4, 2024
January 4, 2024
Half-Year results (April 2023 – September 2023)
December 19, 2023
December 19, 2023
MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program
November 13, 2023
November 13, 2023
MedinCell at the 2023 Jefferies Global Healthcare Conference -London, 14-16 November
November 6, 2023
November 6, 2023
MedinCell and the European Investment Bank (EIB) have replaced a financial covenant of their ongoing loan agreement to better fit with MedinCell business model
